We are live on
!
Find out more
PM
Prosight Management Portfolio holdings
AUM
$610M
1-Year Est. Return
40.86%
This Fund
S&P 500
This Quarter
Est. Return
-3.33%
1 Year Est. Return
+40.86%
3 Year Est. Return
+46.17%
5 Year Est. Return
+1.2%
10 Year Est. Return
–
AUM
$182M
AUM Growth
+$21.8M
(+14%)
Cap. Flow
+$28.1M
Cap. Flow
% of AUM
15.45%
Top 10 Holdings %
Top 10 Hldgs %
56.02%
Holding
60
New
14
Increased
20
Reduced
9
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$10.6M |
| 2 |
ALBO
Albireo Pharma Inc
ALBO
|
+$4.64M |
| 3 |
ACCD
Accolade Inc
ACCD
|
+$4.6M |
| 4 |
AMED
Amedisys
AMED
|
+$4.16M |
| 5 |
Humana
HUM
|
+$3.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prothena Corp
PRTA
|
+$6.13M |
| 2 |
Haemonetics
HAE
|
+$6.04M |
| 3 |
Encompass Health
EHC
|
+$4.46M |
| 4 |
RCM
R1 RCM Inc. Common Stock
RCM
|
+$3.82M |
| 5 |
Zimmer Biomet
ZBH
|
+$2.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.68% |
| 2 | Industrials | 2.27% |
| 3 | Financials | 1.02% |
| 4 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Option Care Health
OPCH
$3.4B
| – | – |
-27,875
| Closed | -$610K |
|
52
Quantum-Si Incorporated
QSI
$168M
| – | – |
-227,391
| Closed | -$2.79M |
|
53
X4 Pharmaceuticals
XFOR
$363M
| – | – |
-2,927
| Closed | -$571K |
|
|
OKUR
54
OnKure Therapeutics
OKUR
$166M
| – | – |
-5,493
| Closed | -$513K |
|
|
RCM
55
DELISTED
R1 RCM Inc. Common Stock
RCM
| – | – |
-171,817
| Closed | -$3.82M |
|
|
CANO
56
DELISTED
Cano Health, Inc.
CANO
| – | – |
-232
| Closed | -$281K |
|
|
AKU
57
DELISTED
Akumin Inc
AKU
| – | – |
-327,680
| Closed | -$1.03M |
|
|
ALBO
58
CALL
DELISTED
Albireo Pharma Inc
ALBO
| – | – |
-32,900
| Closed | -$1.16M |
|
|
LHCG
59
DELISTED
LHC Group LLC
LHCG
| – | – |
-9,888
| Closed | -$1.98M |
|
|
ATIP
60
DELISTED
ATI Physical Therapy, Inc.
ATIP
| – | – |
-3,466
| Closed | -$1.65M |
|
Similar funds
PL
BFC
DCM
SAM
CBB
AIG
FFWA
CIP
Prosight Management's Q3 2021 Portfolio in Review
As of Q3 2021, Prosight Management held 60 positions worth $182M, up 14% from $160M the previous quarter. Its ten largest holdings account for 56% of the portfolio.
Prosight Management deployed $28.1M of net new capital in Q3 2021, opening 14 new positions and adding to 20 existing holdings. Its largest new stake was Accolade Inc: 97,988 shares worth $4.13M.
By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 95% a quarter earlier, followed by Industrials and Financials.
On the sell side, the largest reduction was Prothena Corp, an estimated $6.13M trimmed.
- Prosight Management's largest Q3 2021 buy was Accolade Inc: 97,988 shares worth $4.13M.
- Prosight Management added most to Lakefront Biotherapeutics American Depositary Shares in Q3 2021, an estimated $10.6M increase.
- Prosight Management's biggest Q3 2021 reduction was Prothena Corp, cutting an estimated $6.13M.
- Prosight Management fully exited R1 RCM Inc. Common Stock in Q3 2021, selling an estimated $3.82M.
- Prosight Management's ten largest holdings make up 56% of its $182M portfolio in Q3 2021.
- Prosight Management opened 14 new positions and closed 17 in Q3 2021.
- Prosight Management's portfolio value rose 14% quarter-over-quarter to $182M.
Based on Prosight Management's 13F filing for Q3 2021, filed 12 Nov 2021.